FDA panel recommends approval for computer-assisted mammography screening device
This article was originally published in Clinica
Executive Summary
An FDA advisory committee has unanimously recommended that the US agency approve, with labelling conditions, a computer-assisted device which picks out suspect areas on mammograms. The M1000 ImageChecker System, made by R2 Technology, will be used as an aid to radiologists while screening mammograms.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.